FDA Inspection
Paradox IncParadox Inc – FDA Inspection, Nov 6, 2017
Record Details
This FDA Inspection record concerns Paradox Inc, with an inspection on November 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7c88bffc-d9eb-4819-b92b-5b5f387dff84
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031191
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Paradox Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2024 | Not classified | Kansas City District Office | |
| August 4, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Paradox Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.